Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
Fatigue induced changes to kinematic and kinetic gait parameters following six minutes of walking in people with multiple sclerosis.
Options in improving respiratory function in multiple sclerosis.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis.
The correlation of HLA-G with multiple sclerosis.
Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry.
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.
Contribution of pannexin1 to experimental autoimmune encephalomyelitis.
The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Hospital admission due to infections in multiple sclerosis patients.
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Plant sterols: Friend or foe in CNS disorders?
A rare brain infection with multiple sclerosis dug.
Neuroplasticity and motor rehabilitation in multiple sclerosis.
Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »